Neurocrine Biosciences Inc (NBIX.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|68||2011||Independent Chairman of the Board|
|58||2017||Chief Executive Officer, Director|
|38||2017||Chief Financial Officer|
|51||2015||Chief Commercial Officer|
|59||2012||Chief Development Officer|
- BRIEF-Abbvie Announces Positive Topline Results From Phase 3 Study Evaluating Investigational Elagolix In Women With Uterine Fibroids
- BRIEF-Neurocrine Will File NDA For Opicapone For Parkinson's Disease Based On Existing Pivotal Clinical Trial Data
- BRIEF-Neurocrine Biosciences Reports Q4 Earnings Per Share $0.07
- BRIEF-Neurocrine Biosciences Presents Long-Term Data Analyses From Open-Label Kinect 4 Phase III Study
- BRIEF-Neurocrine Biosciences appoints Matt Abernethy as CFO